Amway in no mood to slash prices despite cost pressures
A wholly-owned entity of the $8.4-billion Amway Corporation of the US, Amway India has no plans to increase its product prices in the near future, despite pressure on input costs.
May 13, 2010 | comments ( 0 ) |
A wholly-owned entity of the $8.4-billion Amway Corporation of the US, Amway India has no plans to increase its product prices in the near future, despite pressure on input costs. In the last 12 years of company’s presence in India, it has increased prices only thrice, the last was a year ago as per William S. Pinckney, Managing Director and CEO, Amway India, who was in India to inaugurate Amway's ‘assessment centre' in Tamil Nadu.
According to him, the company is upbeat about its India business and has plans up its sleeves to expand its product portfolio further. The company is about to launch a range of new products in the health and wellness category. “Health and wellness will remain the company's core focus area as it contributes 50 per cent of the overall turnover here,” Pinckney said.
Amway India currently has 115 products across five categories – health and wellness, personal care, home care, cosmetics and gift catalogue. The total number of its ‘assessment centre’ in the country is nine. Apart from providing business and product information, and being a collection point for its agents the centres are “equipped to provide skin and health assessment and consultancy from specialists”.
- Reliance Retail & Jio to jointly launch new e-commerce platform
- CCI gives nod to Samara Capital-Amazon's joint bid to buy More
- SoftBank eyes 40% stake in FirstCry for $400 million
- Vivo India launches 'Vivo Xchange' program in partnership with Cashify.in
- Milkbasket expands operations to Bengaluru
- Manyavar launches another store in Punjab
- Ola raises Rs 150 crore from Flipkart's Co-Founder Sachin Bansal
- Ananth Narayanan steps down as Myntra Jabong CEO
- DailyNinja celebrates 15 million orders fulfilled
- John Jacobs looks to garner Rs 500 crore revenue by March 2021